J. Viitanen

发表

A randomised comparison of bicalutamide ('Casodex') 150 mg versus placebo as immediate therapy either alone or as adjuvant to standard care for early non-metastatic prostate cancer. First report from the Scandinavian Prostatic Cancer Group Study No. 6.

T. Tammela, J. Johansson, O. Lukkarinen, 2002, European urology.

Functional and urodynamic characteristics of bladder substitution with detubularised right colonic segment.

T. Tammela, O. Lukkarinen, J. Viitanen, 1991, British journal of urology.

The prognostic value of inducible nitric oxide synthase in local prostate cancer

V. Kosma, P. Lipponen, S. Aaltomaa, 2000, BJU international.

Prognostic Value of CD44 Standard, Variant Isoforms 3 and 6 and ·–Catenin Expression in Local Prostate Cancer Treated by Radical Prostatectomy

V. Kosma, P. Lipponen, S. Aaltomaa, 2000, European Urology.

Transurethral Prostatectomy in Patients with Preoperative Bacteriuria: Double-Blind Study with Oral Fleroxacin and Cefalexin

T. Tammela, J. Kallio, K. Malminiemi, 1997, Chemotherapy.

Neoadjuvant Chemotherapy Does Not Increase the Morbidity of Radical Cystectomy: A 10-year Retrospective Nationwide Study.

P. Boström, M. Vaarala, T. Murtola, 2018, European urology oncology.

Finnish multicenter study comparing intermittent to continuous androgen deprivation for advanced prostate cancer: interim analysis of prognostic markers affecting initial response to androgen deprivation.

T. Tammela, K. Taari, M. Ala-opas, 2008, The Journal of urology.

Analysis of false-positive BTA STAT test results in patients followed up for bladder cancer.

O. Lukkarinen, E. Kaasinen, M. Raitanen, 2001, Urology.

The FinnProstate Study VII: intermittent versus continuous androgen deprivation in patients with advanced prostate cancer.

T. Tammela, K. Taari, M. Ala-opas, 2012, The Journal of urology.

Strong Stromal Hyaluronan Expression Is Associated with PSA Recurrence in Local Prostate Cancer

V. Kosma, P. Lipponen, S. Aaltomaa, 2002, Urologia Internationalis.

Ceftazidime vs. tobramycin for serious infections in urological patients.

T. Tammela, K. Jauhiainen, J. Viitanen, 1990, The Journal of hospital infection.

Factors explaining recurrence in patients undergoing chemoimmunotherapy regimens for frequently recurring superficial bladder carcinoma.

E. Kaasinen, H. Juusela, J. Viitanen, 2002, European urology.

Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: Part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5

P. Klarskov, P. Iversen, E. Varenhorst, 2008, Scandinavian journal of urology and nephrology.

Randomized controlled study of chemoprophylaxis in transurethral prostatectomy.

M. Nurmi, J. Viitanen, E. Rintala, 1993, The Journal of urology.

Long-term outcome of patients with frequently recurrent non-muscle-invasive bladder carcinoma treated with one perioperative plus four weekly instillations of mitomycin C followed by monthly bacillus Calmette-Guérin (BCG) or alternating BCG and interferon-α2b instillations: prospective randomised Fi

P. Boström, S. Aaltomaa, M. Vaarala, 2015, European urology.

Advanced prostate cancer treated with intermittent or continuous androgen deprivation in the randomised FinnProstate Study VII: quality of life and adverse effects.

T. Tammela, K. Taari, M. Ala-opas, 2013, European urology.

Effect of oral clodronate on bone pain

T. Tammela, K. Jauhiainen, O. Alfthan, 1992, International Urology and Nephrology.

Orchiectomy versus oestrogen in the treatment of advanced prostatic cancer.

O. Alfthan, M. Ruutu, M. Ala-opas, 1991, British journal of urology.

Comparison of intermittent and continuous androgen deprivation and quality of life between patients with locally advanced and patients with metastatic prostate cancer: a post hoc analysis of the randomized FinnProstate Study VII

T. Tammela, A. Sankila, K. Taari, 2014, Scandinavian journal of urology.